Cumberland Pharmaceuticals Inc.
General ticker "CPIX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $53.0M (TTM average)
Cumberland Pharmaceuticals Inc. does not follow the US Stock Market performance with the rate: -18.1%.
Estimated limits based on current volatility of 4.3%: low 2.21$, high 2.41$
Factors to consider:
- Total employees count: 91 (0.0%) as of 2024
- Countries other than US accounted for 7.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Market competition, Regulatory and compliance, Supply chain disruptions, Cybersecurity threats
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.51$, 2.95$]
- 2025-12-31 to 2026-12-31 estimated range: [1.39$, 2.78$]
Financial Metrics affecting the CPIX estimates:
- Positive: with PPE of -29.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.85 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 30.24 <= 41.86
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: Inventory ratio change, % of -0.88 <= -0.75
- Positive: Investing cash flow per share per price, % of 0.18 > -0.66
Short-term CPIX quotes
Long-term CPIX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $42.01MM | $39.55MM | $37.87MM |
| Operating Expenses | $47.72MM | $49.11MM | $44.30MM |
| Operating Income | $-5.70MM | $-9.55MM | $-6.43MM |
| Non-Operating Income | $0.12MM | $3.27MM | $-0.03MM |
| Interest Expense | $0.59MM | $0.67MM | $0.61MM |
| R&D Expense | $6.69MM | $5.83MM | $4.82MM |
| Income(Loss) | $-5.58MM | $-6.28MM | $-6.47MM |
| Taxes | $0.07MM | $0.05MM | $-0.02MM |
| Profit(Loss)* | $-5.57MM | $-6.28MM | $-6.48MM |
| Stockholders Equity | $36.27MM | $29.60MM | $22.85MM |
| Inventory | $9.86MM | $4.61MM | $4.00MM |
| Assets | $92.93MM | $81.78MM | $75.58MM |
| Operating Cash Flow | $8.45MM | $6.09MM | $-0.61MM |
| Capital expenditure | $2.07MM | $0.45MM | $0.18MM |
| Investing Cash Flow | $-13.67MM | $-0.11MM | $0.06MM |
| Financing Cash Flow | $-2.06MM | $-7.42MM | $0.20MM |
| Earnings Per Share** | $-0.38 | $-0.44 | $-0.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.